Ann: MND Biomarkers and Pharmacodynamics Results, page-88

First 88 Last

Share
Profile

Follow
cainy

383 Posts.

66

05/07/23

08:07

Post #: 68623213
Share

Originally posted by Quiltman: ↑

After the recent trial update "quoted below", I had expected the p75 results before those announced today, as they were still pending at the time

The p75 ECD study results have now been received from Flinders University in Adelaide and will beformally interpreted by a pharmacologist and will be announced as soon as possible.An analysis being conducted at the Florey Institute in Melbourne evaluating p-RPS6KB1 and pEIF4EBP1 is still pending. Further, highly specialised testing of Neurofilament Light Chain (NfL) is beingconducted at the University of Tasmania which is expected in the coming weeks.

So
1/ We can expect the pharmacologist to conclude their interpretation of p75 soon, and this data released.
2/ NfL results in and published
3/ Cohort 2 results for p-RPS6KB1 and pEIF4EBp1 published

Triple punch coming your way.

Should this data all be overwhelming positive, surely the PR machine kicks into gear, FightMND start singing from the rooftops ( and so they should, what an effort ), and next steps announced by PAA, which must include a meeting with the FDA to have a chat about getting MPL to MND suffers ASAP.

Wow. All this for a $25M MC.

Expand

That's a great summary Quiltman and as you pointed out a Market Cap of 25 million.

If results continue positive there will be a stampede coming to buy PAA shares and it is only around the corner and not just mum dad investors it will be fund managers, high end money together with a tight register of shares a perfect storm is brewing.

Keep bringing results!

PAA Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%